Home › Psoriatic Arthritis › Texas
Psoriatic Arthritis clinical trials in Texas
17 studies for Psoriatic Arthritis are looking for participants at sites in Texas.
Cities in Texas
- Houston8 studies
- Baytown4 studies
- The Woodlands4 studies
- Dallas4 studies
- Arlington4 studies
- Lubbock3 studies
- Mesquite3 studies
- Fort Worth3 studies
- Austin3 studies
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
- UT Southwestern, Dallas
- Arthritis and Rheumatology Research Institute, Frisco
- AARA Clinical Research Lone Star Arthritis and Rheumatology, Irving
- and 2 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06807424A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis
- Arthritis and Rheumatology Research Institute, Frisco
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07321873A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
- Precision Comprehensive Research, Colleyville
- Rheumatology Associates of South Texas, San Antonio
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 25, 2026 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Accurate Clinical Research, Baytown
- Novel Research | Bellaire Location, Bellaire
- Novel Research | Bellaire Location, Bellaire
- and 5 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT06671483Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
- Greater Houston Rheumatology ( Site 5103), Houston
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 14, 2026 · NCT07486960Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
- Clinical Site, Austin
- Clinical Site, Baytown
- Clinical Site, Colleyville
- and 1 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 11, 2026 · NCT06641089A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
- AARR- Lone Star Arthritis & Rheumatology Associates, Fort Worth
- Biopharma Informatic | Hassan, Houston
- Advanced Rheumatology of Houston - The Woodlands, The Woodlands
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT06671496Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Accurate Clinical Research, Baytown
- Novel Research LLC, Bellaire
- Novel Research | Abigail Neiman - Houston, TX, Houston
- and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07286058Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
- UT Southwestern Medical Center, Dallas
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07280702A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Child Neurology Consultants of Austin /ID# 260562, Austin
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- University of Texas Southwestern Medical Center Dallas, Dallas
- Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
RecruitingObservational study
Up to age 21 · All sexes · Updated Aug 27, 2026 · NCT02418442A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
- Pa0019 129, Baytown
- Pa0019 136, Colleyville
- Pa0019 135, Mesquite
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 6, 2026 · NCT07290036Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT04751396Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
- Tekton Research - West Gate /ID# 272765, Austin
- Accurate Clinical Research - Houston /ID# 272754, Houston
- Tekton Research, LLC /ID# 272901, San Antonio
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 18, 2025 · NCT06865105Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
- Heritage Rheumatology and Arthritis Care, Colleyville
- Texas Arthritis Center, El Paso
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Oct 9, 2025 · NCT05669833From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.